Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Plos One|October 29, 2015
Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-2-Quinolone Derivatives: A new Class of Integrin AntagonistsSandrine Fiorucci, Xiaochen Lin, Karin Sadoul, et al.Nuclear Medicine and Biology|November 14, 2007
Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligandSandrine Tang, Mathieu Verdurand, Benoît Joseph, et al.Talanta|May 2, 2026
Scout-triggered MRM from untargeted data: An R-based strategy for multiplexed targeted metabolomicsRémy De Boni, Guillaume Rossignol, Delphine Arquier, et al.Molecular Cancer Therapeutics|September 16, 2008
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitineKarima Bettayeb, Hatem Sallam, Yoan Ferandin, et al.Chemico-Biological Interactions|June 17, 2026
Resorufin-derived esters as fluorescent probes to test for the esterase activity and active-site topology of aldehyde dehydrogenaseRaquel Pequerul, Daniela Covaleda, Andrés S Sánchez-Vaca, et al.Biomedicines|October 28, 2023
Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening SystemJulie Carrard, Fiona Ratajczak, Joséphine Elsens, et al.European Journal of Medicinal Chemistry|August 19, 2007
Aldehyde dehydrogenase inhibitors: alpha,beta-acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but irreversible apoptogens for cancer epithelial cells from human prostate in cultureGerard Quash, Guy Fournet, Charlotte Courvoisier, et al.European Journal of Medicinal Chemistry|January 28, 2012
Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivativesDaniel B Nichols, Guy Fournet, K R Gurukumar, et al.Journal of Medicinal Chemistry|January 9, 2009
Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogueFlorence Popowycz, Guy Fournet, Cédric Schneider, et al.Plos One|December 14, 2018
Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosisNavina L Chrobok, John G J M Bol, Cornelis A Jongenelen, et al.Pageof 3